drugset / Trial / NCT04283240
Sildenafil in Acute Pulmonary Embolism
RandomizedParallel-groupQuadruple-blindBasic science
Summary
To investigate if acute pulmonary vasodilation by sildenafil improves right ventricular function in patients with acute intermediate-high risk pulmonary embolism (PE).
Timeline
- Start
- 2015-03-01
- Primary completion
- 2017-09-10
- Completion
- 2018-09-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sildenafil | Unknown | 50 mg | Oral |